Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Research ArticleChoosing Wisely Canada

Reduce unnecessary routine vitamin D testing

Alexander G. Singer and Christopher McChesney
Canadian Family Physician September 2023; 69 (9) 620-622; DOI: https://doi.org/10.46747/cfp.6909620
Alexander G. Singer
Associate Professor and Director of Research and Quality Improvement in the Department of Family Medicine at the University of Manitoba in Winnipeg and Director of the Manitoba Primary Care Research Network.
MB BAO BCh CCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher McChesney
Resident in internal medicine at Western University in London, Ont, and was a summer student with Choosing Wisely Canada at the time this article was written.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Case introduction

Laura is a 40-year-old engineer of eastern European ancestry who presents to your office to request testing of her vitamin D levels. She generally wears sunscreen in the summer and wears sun-protective clothing year round. She is fairly healthy, eating a balanced diet high in fresh fruits and vegetables, but experiences migraines for which she takes triptans for rescue about 4 times per year. She and her partner own a house in a middle-class neighbourhood where they live with their son. Laura informs you that her mother has been taking vitamin D supplements for many years based on her doctor’s recommendations to improve her bone health. Additionally, Laura tells you that her neighbour, a nurse about her age, recently had her vitamin D levels checked and they were “very low,” so she has considered starting vitamin D supplementation.

Laura is hoping that by testing her vitamin D levels she will know how much supplementation she needs to take to protect her from COVID-19, cancer, and fractures as she gets older. Laura is worried that her levels might be low because she avoids direct sunlight and is concerned that she may be missing an easy opportunity to improve her health with supplementation she can afford.

In many family medicine practices, requests for tests by patients are a common occurrence. These requests might occur as part of visits about preventive health matters or be prompted by patient concerns. In the case of routine testing of vitamin D levels, literature suggests that it is driven by several factors, including media attention describing correlational studies connecting lack of vitamin D to various health concerns, and physicians promoting its use.1-10 During the height of the COVID-19 pandemic there were reports on studies that described associations between vitamin D deficiency and morbidity or mortality due to COVID-19 infection.11-14

Multiple evidence-synthesizing organizations, including Choosing Wisely Canada, Osteoporosis Canada, the United Kingdom (UK) National Institute for Health and Care Excellence, the Royal Australian College of General Practitioners, and the United States (US) Preventive Services Task Force, recommend against testing vitamin D levels in most patients. The reason for the similarity of these recommendations is the consistent evidence demonstrating that in healthy adults low vitamin D levels are not associated with any disease.13,15-21 Of importance, the US Preventive Services Task Force conducted a systematic review in 2021 that did not identify any studies that showed vitamin D screening improved health outcomes.18 The same study also did not find it caused any direct harms.

Costs and provider burden

For health systems focused on trying to achieve the Quadruple Aim,22 reducing vitamin D testing can be an achievable means to do so. Studies from the UK, the US, Canada, and Australia suggest that up to 75% of vitamin D testing may be unnecessary.9,23-27 Reductions in unnecessary vitamin D testing limit provider burden to follow up on results, do not impact patient experiences or outcomes, and improve the value of health care expenditures.

In many cases it is simpler to order a vitamin D test in response to a patient’s request; however, doing so may be potentially harmful to patients due to the unnecessary testing cascade that can follow an abnormal result.28 Additionally, because of the lack of evidence to support any kind of routine or follow-up vitamin D measurements, in some Canadian jurisdictions testing is no longer insured or even available without specific medical information, thus causing patients who may not be able to afford testing to incur a direct cost.29,30 Finally, health care budgets are not infinite and family physicians should be considerate of their role as stewards of this limited resource. The annual, not-insignificant cost of vitamin D testing is estimated to be approximately £17 million in the UK,31 A$104.7 million in Australia,32 $30 million in Canada,25 and $293 million (US) in the US.25

Unnecessary testing

Perhaps the most salient reason why routine vitamin D testing is unnecessary is that supplementation can be started regardless of blood levels. In fact, some guidelines continue to recommend vitamin D supplementation, particularly in northern climates such as Canada’s, regardless of blood levels.13,33 Vitamin D supplementation, particularly in northern climates and for patients with dark or pigmented skin, is still recommended by some guidelines despite any specific link to patient-oriented outcomes.13,18,34 In fact, a large randomized trial demonstrated supplemental vitamin D does not reduce the risk of fracture in older adults, even in those with low baseline levels or a previous fracture.35

Stewardship

Family physicians may be concerned that restricting testing in patients will negatively impact patient experience. However, there is strong evidence from stewardship efforts in primary care environments that patients are satisfied if they believe that the physician has listened to their concerns even if they did not receive a requested test.36-38 An approach to patients who request care that “seems unreasonable” by the Canadian Task Force on Preventive Health Care can be found in Figure 1.39

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Approach for when patients’ requests seem unreasonable

In a recent article in the BMJ, we outlined several practice-level strategies to support family physicians and health care system stakeholders who are interested in reducing vitamin D testing.40 Discussion support tools can assist family physicians with the difficult conversations that can occur regarding vitamin D testing if they are inclined not to order unnecessary testing.39,41,42 Sharing information allows patients and physicians to achieve a better understanding of health concerns and reach an agreement on goals.43 Moreover, requests for vitamin D testing can create opportunities for better patient engagement and moments to use shared decision-making skills.43

Box 1 is reproduced from our BMJ article and provides tips to help family physicians explore patient concerns that drive this type of request for testing.40 There are also several strategies outlined in our article on how to reduce unnecessary vitamin D testing using evidence-based approaches to quality improvement.40

Box 1.

Examples of questions and responses for a conversation with patients requesting vitamin D testing

Patient: “I would like a vitamin D level to test my status.”

Physician (options to respond):

  • “There is a lot of attention to vitamin D. What have you read or heard that leads you wonder about this?”

  • “I would like to understand what you are most concerned about that leads to your request.”

Patient: “I’ve heard that deficiency in vitamin D can cause [disease or concern].”

Physician (validation):

  • “Oh, I can understand your concern about [name it specifically].”

  • “Perhaps I can tell you more about that issue and we can then decide together whether you need a vitamin D level or not.”

Physician (information exchange—brief and avoid medical jargon):

  • Present key information about the patient’s specific concern; how we get vitamin D from sunlight or supplements; the high-risk groups that can be vitamin D deficient (indicating whether the patient is in any of these); and the best evidence about not testing but using supplementation

Physician (check in and respond to questions):

  • “What do you think of the information I presented? How does this fit for you?”

  • Address patient questions and come to a shared decision

Reproduced from McChesney et al.40

Case resolution

Upon further discussion with Laura regarding her interest in vitamin D testing, she reveals that a friend was recently diagnosed with cervical cancer and she had an uncle die from COVID-19. You review her chart and note that she is due for her cervical cancer screening, which can be done at a follow-up visit. You are able to reassure her that since she has been vaccinated against COVID-19 her risk of serious illness and death is substantially reduced and there is no evidence that vitamin D supplementation will impact her future risk. She remains interested in taking vitamin D in the winter since she can afford it, so you inform her that while it is not necessary, it has also not been shown to be harmful. At an upcoming practice meeting you suggest to your colleagues that they consider a practice audit of vitamin D testing and an education session to review current recommendations on the topic.

Conclusion

While vitamin D testing is mostly benign, it can harm patients by exposing them to unnecessary concern and testing cascades that can cause harm. It is important for family physicians to be active stewards of limited health resources, and illuminating unnecessary routine testing of vitamin D is a viable means to reduce health care costs with no evidence of impact on patient outcomes.

Acknowledgment

We thank Drs Wendy Levinson, Guylène Thériault, and Janet Reynolds for assistance with editing this manuscript.

Notes

Choosing Wisely Canada is a campaign designed to help clinicians and patients engage in conversations about unnecessary tests, treatments, and procedures and to help physicians and patients make smart and effective choices to ensure high-quality care is provided. To date there have been 13 family medicine recommendations, but many of the recommendations from other specialties are relevant to family medicine. Articles produced by Choosing Wisely Canada in Canadian Family Physician are on topics related to family practice where tools and strategies have been used to implement one of the recommendations and to engage in shared decision making with patients. If you are a primary care provider or trainee who has used Choosing Wisely recommendations or tools in your practice and you would like to share your experience, please contact us at info{at}choosingwiselycanada.org.

Footnotes

  • Competing interests

    None declared

  • This article is eligible for Mainpro+ certified Self-Learning credits. To earn credits, go to https://www.cfp.ca and click on the Mainpro+ link.

  • Cet article se trouve aussi en français à la page 623.

  • Copyright © 2023 the College of Family Physicians of Canada

References

  1. 1.↵
    1. Bilinski K,
    2. Boyages S.
    The rise and rise of vitamin D testing. BMJ 2012;345:e4743.
    OpenUrlFREE Full Text
  2. 2.
    1. Sattar N,
    2. Welsh P,
    3. Panarelli M,
    4. Forouhi NG.
    Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012;379(9811):95-6.
    OpenUrlCrossRefPubMed
  3. 3.
    1. Wang TJ,
    2. Pencina MJ,
    3. Booth SL,
    4. Jacques PF,
    5. Ingelsson E,
    6. Lanier K, et al.
    Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117(4):503-11. Epub 2008 Jan 7.
    OpenUrlAbstract/FREE Full Text
  4. 4.
    1. Zipitis CS,
    2. Akobeng AK.
    Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008;93(6):512-7. Epub 2008 Mar 13.
    OpenUrlAbstract/FREE Full Text
  5. 5.
    1. Elvidge S.
    Can vitamin D help protect against COVID? Scientific American 2021 Jun 24. Available from: https://www.scientificamerican.com/article/can-vitamin-d-help-protect-against-covid. Accessed 2023 Aug 2.
  6. 6.
    1. Gallagher J.
    Vitamin D ‘heals damaged hearts’. BBC News 2016 Apr 4. Available from: https://www.bbc.com/news/health-35959556. Accessed 2023 Aug 2.
  7. 7.
    1. Relaxnews
    . Study links IBS to vitamin D deficiency. CTV News 2015 Dec 22. Available from: https://www.ctvnews.ca/health/study-links-ibs-to-vitamin-d-deficiency-1.2710385. Accessed 2023 Aug 2.
  8. 8.
    1. Huber CA,
    2. Nagler M,
    3. Rosemann T,
    4. Blozik E,
    5. Näpflin M,
    6. Markun S, et al.
    Trends in micronutrient laboratory testing in Switzerland: a 7-year retrospective analysis of healthcare claims data. Int J Gen Med 2020;13:1341-8.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Rodd C,
    2. Sokoro A,
    3. Lix LM,
    4. Thorlacius L,
    5. Moffatt M,
    6. Slater J, et al.
    Increased rates of 25-hydroxy vitamin D testing: dissecting a modern epidemic. Clin Biochem 2018;59:56-61. Epub 2018 Jul 17.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Kolata G.
    Why are so many people popping vitamin D? The New York Times 2017 Apr 10. Available from: https://www.nytimes.com/2017/04/10/health/vitamin-d-deficiency-supplements.html. Accessed 2023 Aug 2.
  11. 11.↵
    1. Ali N.
    Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health 2020;13(10):1373-80. Epub 2020 Jun 20.
    OpenUrl
  12. 12.
    1. Pereira M,
    2. Dantas Damascena A,
    3. Galvão Azevedo LM,
    4. de Almeida Oliveira T,
    5. da Mota Santana J.
    Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr 2022;62(5):1308-16. Epub 2020 Nov 4. Addendum in: Crit Rev Food Sci Nutr 2023;63(4):557-62. Epub 2021 Aug 12.
    OpenUrlPubMed
  13. 13.↵
    COVID-19 rapid guideline: vitamin D. London, UK: National Institute for Health and Care Excellence; 2020. Available from: https://www.nice.org.uk/guidance/ng187/resources/covid19-rapid-guideline-vitamin-d-pdf-66142026720709. Accessed 2023 Aug 2.
  14. 14.↵
    1. Dunham J.
    More than 80 per cent of hospitalized COVID-19 patients had vitamin D deficiency: study. CTV News 2020 Oct 27. Available from: https://www.ctvnews.ca/health/more-than-80-per-cent-of-hospitalized-covid-19-patients-had-vitamin-d-deficiency-study-1.5162396. Accessed 2023 Aug 3.
  15. 15.↵
    1. Medical Advisory Secretariat
    . Clinical utility of vitamin D testing: an evidence-based analysis. Ont Health Technol Assess Ser 2010;10(2):1-93. Epub 2010 Feb 1.
    OpenUrlPubMed
  16. 16.
    1. Francis R,
    2. Aspray T,
    3. Fraser W,
    4. Macdonald H,
    5. Patel S,
    6. Mavroeidi A, et al.
    Vitamin D and bone health: a practical clinical guideline for patient management. Bath, UK: Royal Osteoporosis Society; 2018. Available from: https://strwebprdmedia.blob.core.windows.net/media/ef2ideu2/ros-vitamin-d-and-bone-health-in-adults-february-2020.pdf. Accessed 2023 Aug 3.
  17. 17.
    1. Arundel P,
    2. Shaw N.
    Vitamin D and bone health: a practical clinical guideline for patient management in children and young people. Bath, UK: Royal Osteoporosis Society; 2018. Available from: https://theros.org.uk/media/54vpzzaa/ros-vitamin-d-and-bone-health-in-children-november-2018.pdf. Accessed 2023 Aug 3.
  18. 18.↵
    1. Kahwati LC,
    2. LeBlanc E,
    3. Weber RP,
    4. Giger K,
    5. Clark R,
    6. Suvada K, et al.
    Screening for vitamin D deficiency in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;325(14):1443-63.
    OpenUrlCrossRefPubMed
  19. 19.
    Guidelines for preventive activities in general practice. 9th ed. East Melbourne, Aust: Royal Australian College of General Practitioners; 2018. Available from: https://www.racgp.org.au/FSDEDEV/media/documents/Clinical%20Resources/Guidelines/Red%20Book/Guidelines-for-preventive-activities-in-general-practice.pdf. Accessed 2023 Aug 3.
  20. 20.
    1. Hanley DA,
    2. Cranney A,
    3. Jones G,
    4. Whiting SJ,
    5. Leslie WD,
    6. Cole DEC, et al.
    Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010;182(12):E610-8. Epub 2010 Jul 12.
    OpenUrlFREE Full Text
  21. 21.↵
    1. College of Family Physicians of Canada
    . Thirteen tests and treatments to question. Toronto, ON: Choosing Wisely Canada; 2023. Available from: https://choosingwiselycanada.org/family-medicine. Accessed 2023 Aug 3.
  22. 22.↵
    1. Bodenheimer T,
    2. Sinsky C.
    From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med 2014;12(6):573-6.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Woodford HJ,
    2. Barrett S,
    3. Pattman S.
    Vitamin D: too much testing and treating? Clin Med (Lond) 2018;18(3):196-200.
    OpenUrlCrossRefPubMed
  24. 24.
    1. Gonzalez-Chica D,
    2. Stocks N.
    Changes to the frequency and appropriateness of vitamin D testing after the introduction of new Medicare criteria for rebates in Australian general practice: evidence from 1.5 million patients in the NPS MedicineInsight database. BMJ Open 2019;9(3):e024797.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Morgen EK,
    2. Naugler C.
    Inappropriate repeats of six common tests in a Canadian city: a population cohort study within a laboratory informatics framework. Am J Clin Pathol 2015;144(5):704-12.
    OpenUrlCrossRefPubMed
  26. 26.
    1. Boyages SC.
    Vitamin D testing: new targeted guidelines stem the overtesting tide. Med J Aust 2016;204(1):18.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Crowe FL,
    2. Jolly K,
    3. MacArthur C,
    4. Manaseki-Holland S,
    5. Gittoes N,
    6. Hewison M, et al.
    Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005-2015. BMJ Open 2019;9(6):e028355.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Rockwell MS,
    2. Wu YX,
    3. Salamoun M,
    4. Hulver MW,
    5. Epling JW.
    Patterns of clinical care subsequent to nonindicated vitamin D testing in primary care. J Am Board Fam Med 2020;33(4):569-79.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Naugler C,
    2. Hemmelgarn B,
    3. Quan H,
    4. Clement F,
    5. Sajobi T,
    6. Thomas R, et al.
    Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open 2017;5(1):E36-9.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Chami N,
    2. Li Y,
    3. Weir S,
    4. Wright JG,
    5. Kantarevic J.
    Effect of strict and soft policy interventions on laboratory diagnostic testing in Ontario, Canada: a Bayesian structural time series analysis. Health Policy 2021;125(2):254-60. Epub 2020 Oct 24.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Bolland MJ,
    2. Avenell A,
    3. Smith K,
    4. Witham MD,
    5. Grey A.
    Vitamin D supplementation and testing in the UK: costly but ineffective? BMJ 2021;372:n484.
    OpenUrlFREE Full Text
  32. 32.↵
    1. Gordon L,
    2. Waterhouse M,
    3. Reid IR,
    4. Neale RE.
    The vitamin D testing rate is again rising, despite new MBS testing criteria. Med J Aust 2020;213(4):155-155.e1. Epub 2020 May 20.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Holick MF,
    2. Binkley NC,
    3. Bischoff-Ferrari HA,
    4. Gordon CM,
    5. Hanley DA,
    6. Heaney RP, et al.
    Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(7):1911-30. Epub 2011 Jun 6. Erratum in: J Clin Endocrinol Metab 2011;96(12):3908.
    OpenUrlCrossRefPubMed
  34. 34.↵
    Position statement: use and interpretation of vitamin D testing. Surry Hills, Aust: Royal College of Pathologists of Australasia; 2019. Available from: https://www.rcpa.edu.au/Library/College-Policies/Position-Statements/Use-and-Interpretation-of-Vitamin-D-Testing. Accessed 2023 Aug 3.
  35. 35.↵
    1. LeBoff MS,
    2. Chou SH,
    3. Ratliff KA,
    4. Cook NR,
    5. Khurana B,
    6. Kim E, et al.
    Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med 2022;387(4):299-309.
    OpenUrlCrossRef
  36. 36.↵
    1. Coronado-Vázquez V,
    2. Canet-Fajas C,
    3. Delgado-Marroquín MT,
    4. Magallón-Botaya R,
    5. Romero-Martín M,
    6. Gómez-Salgado J.
    Interventions to facilitate shared decision-making using decision aids with patients in primary health care: a systematic review. Medicine (Baltimore) 2020;99(32):e21389.
    OpenUrlCrossRefPubMed
  37. 37.
    1. Joosten EA,
    2. DeFuentes-Merillas L,
    3. de Weert GH,
    4. Sensky T,
    5. van der Staak CPF,
    6. de Jong CAJ.
    Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008;77(4):219-26. Epub 2008 Apr 16.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Stacey D,
    2. Légaré F,
    3. Lewis K,
    4. Barry MJ,
    5. Bennett CL,
    6. Eden KB, et al.
    Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2017;(4):CD001431.
  39. 39.↵
    1. Thériault G,
    2. Grad R,
    3. Dickinson JA,
    4. Breault P,
    5. Singh H,
    6. Bell NR, et al.
    To share or not to share. When is shared decision making the best option? Can Fam Physician 2020;66:327-31 (Eng), e149-54 (Fr).
    OpenUrlFREE Full Text
  40. 40.↵
    1. McChesney C,
    2. Singer A,
    3. Duquette D,
    4. Forouhi NG,
    5. Levinson W.
    Do not routinely test for vitamin D. BMJ 2022;378:e070270.
    OpenUrlFREE Full Text
  41. 41.↵
    1. Stiggelbout AM,
    2. Van der Weijden T,
    3. De Wit MPT,
    4. Frosch D,
    5. Légaré F,
    6. Montori VM, et al.
    Shared decision making: really putting patients at the centre of healthcare. BMJ 2012;344:e256. Erratum in: BMJ 2012;344:e863.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Légaré F,
    2. Adekpedjou R,
    3. Stacey D,
    4. Turcotte S,
    5. Kryworuchko J,
    6. Graham ID, et al.
    Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database Syst Rev 2018;(7):CD006732.
  43. 43.↵
    1. Abrams EM,
    2. Shaker M,
    3. Oppenheimer J,
    4. Davis RS,
    5. Bukstein DA,
    6. Greenhawt M.
    The challenges and opportunities for shared decision making highlighted by COVID-19. J Allergy Clin Immunol Pract 2020;8(8):2474-80.e1. Epub 2020 Jul 14.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Family Physician: 69 (9)
Canadian Family Physician
Vol. 69, Issue 9
1 Sep 2023
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reduce unnecessary routine vitamin D testing
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Reduce unnecessary routine vitamin D testing
Alexander G. Singer, Christopher McChesney
Canadian Family Physician Sep 2023, 69 (9) 620-622; DOI: 10.46747/cfp.6909620

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Reduce unnecessary routine vitamin D testing
Alexander G. Singer, Christopher McChesney
Canadian Family Physician Sep 2023, 69 (9) 620-622; DOI: 10.46747/cfp.6909620
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Case introduction
    • Costs and provider burden
    • Unnecessary testing
    • Stewardship
    • Case resolution
    • Conclusion
    • Acknowledgment
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • Réduire les dosages systématiques inutiles de la vitamine D
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Reducing the use of proton pump inhibitors in infants with gastroesophageal reflux symptoms
  • How to decrease routine and repetitive blood tests in hospitalized patients
  • When urine testing to rule out infection does more harm than good
Show more Choosing Wisely Canada

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire